Source comparison
CJC-1295 No DAC Dosage for Natural GH Rhythm: Research Protocol Comparison
Minimal Protocol 100–150mcg Once daily (pre-sleep) 700–1,050mcg Nocturnal pulse amplification only Very low. Preserves daily receptor reset Best for long-term protocols (12+ weeks) where sustainability matters more than peak amplitude Standard Protocol 100–200
This comparison does not assign a generated winner or score.
- Minimal Protocol
- 100–150mcg
- Once daily (pre-sleep)
- 700–1,050mcg
- Nocturnal pulse amplification only
- Very low. Preserves daily receptor reset
- Best for long-term protocols (12+ weeks) where sustainability matters more than peak amplitude
- Standard Protocol
- 100–200mcg
- Twice daily (post-workout + pre-sleep)
- 1,400–2,800mcg
- Exercise-induced and nocturnal pulses
- Low if doses remain ≤200mcg per injection
- Optimal balance for most research contexts. Captures two major pulse windows without oversaturation
- Aggressive Protocol
- 150–200mcg
- Three times daily (fasted AM + post-workout + pre-sleep)
- 3,150–4,200mcg
- All three major circadian pulse windows
- Moderate to high if sustained beyond 8–12 weeks
- Reserved for short-term protocols or competitive research phases. Requires IGF-1 monitoring to detect early receptor blunting
- Cycled Protocol
- 200mcg
- Once daily 5 days/week (weekdays only)
- 1,000mcg
- Preserves weekend receptor sensitivity reset
- Very low. Built-in recovery prevents downregulation
- Underutilized approach that extends protocol viability. Weekend breaks allow full receptor repopulation
- The table above assumes subcutaneous injection and bacteriostatic water reconstitution. Intramuscular administration is possible but offers no bioavailability advantage for GHRH analogs and increases injection site discomfort.